---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-002377"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2025-01-15T23:59:59+00:00"
generated_at: "2026-05-28T01:08:21.178688+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Hepion Pharma receives Nasdaq delisting notice for failure to hold annual meeting; 45 days to submit compliance plan

## Summary
- Notice dated January 14, 2025 from Nasdaq for failing to hold annual shareholders' meeting within 12 months of fiscal year end.
- Company has 45 days to submit a plan to regain compliance; intends to do so.
- If plan accepted, Nasdaq may grant extension to June 30, 2025; if not, company can appeal.
- Common stock (HEPA) continues trading on Nasdaq Capital Market during the process.
- No assurance that listing will be maintained.

## SEC filing metadata
- accession: 0001493152-25-002377
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2025-01-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000149315225002377/0001493152-25-002377-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000149315225002377/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-002377
- JSON: https://secwatch.observer/filing/0001493152-25-002377.json
- Plain text: https://secwatch.observer/filing/0001493152-25-002377.txt

## Source-grounded claims
- claim_id: 56fd2a08e3996f0ec2819ed5b64a843cbcda8314
  claim: Hepion Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding shareholders.
  evidence_excerpt: January 14, 2025, Hepion Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), received written notice (the “ Notice ”) from the Nasdaq Stock Market, LLC (“ Nasdaq ”) indicating that since the Company had not
  evidence_url: https://www.sec.gov/Archives/edgar/data/1583771/000149315225002377/0001493152-25-002377-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.